Century Therapeutics (IPSC) Shares Issued (2021 - 2026)
Century Therapeutics (IPSC) reported Shares Issued of $202000.0 for Q1 2026, up 68.33% year-over-year from $120000.0 in Q1 2025, and up 281.13% quarter-over-quarter from $53000.0 in Q4 2025.
Century Therapeutics (IPSC) Shares Issued (2021 - 2026) Analysis & Trends
Century Therapeutics (IPSC) has 6 years of Shares Issued data on file, last reported at $202000.0 in Q1 2026.
- Shares Issued for Q1 2026 came in at $202000.0, up 68.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $255000.0 (up 342.86% YoY), and the FY2025 annual result was $173000.0, up 22.7% from the prior year.
- Shares Issued grew to $202000.0 in Q1 2026 per IPSC's latest filing, from $53000.0 in the prior quarter.
- Over five years, Shares Issued peaked at $26.7 million in Q2 2022 and troughed at -$26.6 million in Q3 2022.
- A 5-year average of $1.9 million and a median of $124000.0 in 2023 frame the typical range for Shares Issued.
- On a YoY basis, Shares Issued climbed as much as 1383.86% in 2022 and fell as far as 2656400.0% in 2022.
- A 5-year view of Shares Issued shows it stood at $26.6 million in 2022, then plunged by 101.34% to -$356000.0 in 2023, then plunged by 69.1% to -$602000.0 in 2024, then surged by 108.8% to $53000.0 in 2025, then jumped by 281.13% to $202000.0 in 2026.
- Business Quant data shows IPSC's Shares Issued at $202000.0 in Q1 2026, $53000.0 in Q4 2025, and $120000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 5.40 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 27.00 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 26,927.15 |
| 10 | Century Therapeutics | 444.99 Mn | 444.99 Mn | - | 202,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 202,000.00 |
| Mar 31, 2026 | 202,000.00 |
| Dec 31, 2025 | 53,000.00 |
| Dec 31, 2025 | 53,000.00 |
| Mar 31, 2025 | 120,000.00 |
| Mar 31, 2025 | 120,000.00 |
| Dec 31, 2024 | -602,000.00 |
| Dec 31, 2024 | -602,000.00 |
| Sep 30, 2024 | 273,000.00 |
| Sep 30, 2024 | 273,000.00 |
| Jun 30, 2024 | 104,000.00 |
| Jun 30, 2024 | 104,000.00 |
| Mar 31, 2024 | 366,000.00 |
| Mar 31, 2024 | 366,000.00 |
| Dec 31, 2023 | -356,000.00 |
| Dec 31, 2023 | -356,000.00 |
| Sep 30, 2023 | 300,000.00 |
| Sep 30, 2023 | 300,000.00 |
| Jun 30, 2023 | 124,000.00 |
| Jun 30, 2023 | 124,000.00 |